ECO Animal Health Group plc (EAH.L)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. David Charles Hallas | CEO & Director | 586k | -- | 1964 |
Mr. Christopher Wilks ACA, BSc, F.C.A. | CFO, Finance Director, Secretary & Director | 470k | -- | 1964 |
Mr. Andrew Buglass | Chief Commercial Officer | -- | -- | -- |
ECO Animal Health Group plc
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 227
Description
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, lices, and mange in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.
Corporate Governance
Upcoming Events
July 14, 2025 at 10:59 AM UTC - July 18, 2025 at 12:00 PM UTC
ECO Animal Health Group plc Earnings Date
Recent Events
September 23, 2021 at 12:00 AM UTC
Ex-Dividend Date